Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | NPY1R | P25929 | 1/20 | 0.32 |
| ▸ | NPY2R | P49146 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 2/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21586206 | 0.89 | MAPT (0.37) | MAPTSMN1; SMN2ALDH1A1PKMKMT2A | |
| SCHEMBL17422370 | 0.86 | POLB (0.40) | MAPTSMN1; SMN2ALDH1A1PKMKMT2A | |
| SCHEMBL30107041 | 0.86 | SMN1; SMN2 (0.39) | MAPTSMN1; SMN2ALDH1A1PKMKMT2A | |
| SCHEMBL17732146 | 0.86 | SMN1; SMN2 (0.39) | MAPTSMN1; SMN2ALDH1A1PKMKMT2A | |
| Hydrochloric Acid SCHEMBL28618285 | 0.84 | POLB (0.39) | MAPTSMN1; SMN2ALDH1A1PKMKMT2A | |
| SCHEMBL30989780 | 0.84 | SMN1; SMN2 (0.38) | MAPTSMN1; SMN2ALDH1A1PKMKMT2A | |
| SCHEMBL25887585 | 0.84 | SMN1; SMN2 (0.38) | MAPTSMN1; SMN2ALDH1A1PKMKMT2A | |
| SCHEMBL17422436 | 0.84 | MAPT (0.38) | MAPTSMN1; SMN2ALDH1A1PKMKMT2A | |
| SCHEMBL30969148 | 0.82 | HPGD (0.42) | MAPTSMN1; SMN2ALDH1A1KMT2AMEN1 | |
| SCHEMBL25210087 | 0.82 | HPGD (0.42) | MAPTSMN1; SMN2ALDH1A1KMT2AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3848362-B1 | HETEROARYL AZOLE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO (JP) | 2025-10-29 | — | — | EP | disclosed |
| US-12180178-B2 | Heteroaryl azole compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2024-12-31 | — | — | US | disclosed |
| EP-4455135-A2 | HETEROARYL AZOLE COMPOUND AND PEST CONTROL AGENT | Nippon Soda Co., Ltd. (JP) | 2024-10-30 | — | — | EP | disclosed |
| US-20240327377-A1 | HETEROARYL AZOLE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2024-10-03 | — | — | US | disclosed |
| EP-3848362-A1 | HETEROARYL AZOLE COMPOUND AND PEST CONTROL AGENT | Nippon Soda Co., Ltd. (JP) | 2021-07-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240327377-A1 | HETEROARYL AZOLE COMPOUND AND PEST CONTROL AGENT | INF2, CRY2, CRY1 | MAPT 379/4885SMN1; SMN2 1194/4885ALDH1A1 4254/4885 |
| US-12180178-B2 | Heteroaryl azole compound and pest control agent | CRY1, CRY2, H1-2 | MAPT 329/4885SMN1; SMN2 2590/4885ALDH1A1 4574/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.